Ушбу иш иқтибос қилган ишлар

213 та иш

Иш: Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

   Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37

   Мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.296830

2. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

   Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35

   Мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475807

3. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR

   Dana Stenger, Tanja A. Stief, Theresa Kaeuferle +12

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475820

4. Gene Editing and Genotoxicity: Targeting the Off-Targets

   Georges Blattner, Alessia Cavazza, Adrian J. Thrasher +1

   Шарҳ мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475834

5. CRISPR activation and interference screens decode stimulation responses in primary human T cells

   Ralf Schmidt, Zachary Steinhart, Madeline Layeghi +6

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475858

6. Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

   Sumin Jo, Shipra Das, Alan F. Williams +19

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475864

7. Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

   Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev +2

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475878

8. Current Strategies for Exosome Cargo Loading and Targeting Delivery

   Haifeng Zeng, Shaoshen Guo, Xuancheng Ren +3

   Шарҳ мақола20232 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475892

9. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods

   Yekta Metanat, Patrik Viktor, Ayesha Amajd +10

   Шарҳ мақола20242 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.475922

10. Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy

    Siheng Zhang, Linglong Peng, Yifei Chen +2

    Шарҳ мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475948

11. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

    Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

    Шарҳ мақола20242 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475949

12. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

    Karlo Perica, Nayan Jain, Michael Scordo +23

    Мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475959

13. CD19.CAR T-cell–derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy

    Paola Lanuti, Francesco Guardalupi, Giulia Corradi +32

    Мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475960

14. Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies

    Ahmed Ismail, Mohsen A. Khormi, Wedad Mawkili +6

    Шарҳ мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475971

15. Applications of nanoparticles in CAR-T cell therapy: non-viral manufacturing, enhancing in vivo function, and in vivo generation of CAR-T cells

    Yasmeen A. Albalawi

    Шарҳ мақола20252 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475978

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475791

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475792

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475793

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475794

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475795

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475796

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475797

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475798

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475799

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.475800